Literature DB >> 1305027

Iris nevi and melanomas: a clinical follow-up study.

F van Klink1, R J de Keizer, M J Jager, H M Kakebeeke-Kemme.   

Abstract

A follow-up study of 113 patients with suspicious iris nevi who were referred to our clinic between 1973 and 1991 was carried out by: reviewing their clinical records, fluorescein angiography, obtaining recent data with cooperation of their own or the referring ophthalmologist and contacting patients for reexamination. After examination the diagnoses were: 64 suspicious nevi, 23 melanomas, 15 ciliary body tumors with iris involvement and 11 other pseudomelanomas. In the group of suspicious nevi 86% was localized in the inferior part and 66% in the temporal part of the iris; for the melanoma group these figures were 78% and 75% respectively. The chamber angle was more often involved in the melanoma group, 40% against 17% in the suspicious nevi group. In this group 11 cases (21.6%) showed growth during the follow-up (mean 10.6 years). In three cases the tumor was surgically removed, with as histopathologic diagnosis: 1 xanthogranuloma, 1 neurolemmoma and 1 possible melanoma. In the melanoma group 16 lesions (76%) showed growth during the follow-up (mean 7.2 years), in most cases within 5 years of the initial diagnosis. The lesion was surgically removed in 11 cases. The histopathologic diagnoses were: 8 melanomas, 1 xanthogranuloma, 1 possible melanoma and 1 metastasis of a skin melanoma. Our study shows that periodic ophthalmic check-ups are of great importance in the management of iris lesions suspect for melanoma.

Entities:  

Mesh:

Year:  1992        PMID: 1305027     DOI: 10.1007/bf00156993

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  12 in total

1.  Carcinoma metastatic to the eye and orbit. I. A clinicopathologic study of 227 cases.

Authors:  A P Ferry; R L Font
Journal:  Arch Ophthalmol       Date:  1974-10

2.  Recurrent hemorrhage in the anterior chamber caused by a (juvenile) xanthogranuloma of the iris in an adult.

Authors:  R F Brenkman; J A Oosterhuis; W A Manschot
Journal:  Doc Ophthalmol       Date:  1977-02-28       Impact factor: 2.379

3.  Iris melanomas.

Authors:  L J Geisse; D M Robertson
Journal:  Am J Ophthalmol       Date:  1985-06-15       Impact factor: 5.258

4.  Presumed juvenile xanthogranuloma of the iris and ciliary body in an adult.

Authors:  W E Bruner; W J Stark; W R Green
Journal:  Arch Ophthalmol       Date:  1982-03

5.  The differential diagnosis of malignant melanoma of the iris. A clinical study of 200 patients.

Authors:  J A Shields; G E Sanborn; J J Augsburger
Journal:  Ophthalmology       Date:  1983-06       Impact factor: 12.079

6.  Tumors of the anterior uvea. I. Metastasizing malignant melanoma of the iris.

Authors:  M S Sunba; A H Rahi; G Morgan
Journal:  Arch Ophthalmol       Date:  1980-01

7.  Natural course of melanocytic tumors of the iris.

Authors:  C Territo; C L Shields; J A Shields; J J Augsburger; R P Schroeder
Journal:  Ophthalmology       Date:  1988-09       Impact factor: 12.079

8.  Are most iris "melanomas' really nevi? A clinicopathologic study of 189 lesions.

Authors:  F A Jakobiec; G Silbert
Journal:  Arch Ophthalmol       Date:  1981-12

9.  Anterior uveal melanomas and intraocular pressure.

Authors:  M B Shields; G K Klintworth
Journal:  Ophthalmology       Date:  1980-06       Impact factor: 12.079

10.  Fluorescence angiographical studies in the diagnosis and follow-up of tumors of the iris and ciliary body.

Authors:  U Demeler
Journal:  Adv Ophthalmol       Date:  1981
View more
  4 in total

1.  Conventional diagnostic ultrasound of iris lesions.

Authors:  A M Verbeek
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

2.  Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma.

Authors:  Valerie Schmelter; Sarah Heidorn; Alexander Muacevic; Siegfried G Priglinger; Paul Foerster; Raffael Liegl
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

3.  Topography and clinical features of iris melanoma.

Authors:  Jørgen Krohn; Kristoffer Våge Sundal; Torbjørn Frøystein
Journal:  BMC Ophthalmol       Date:  2022-01-03       Impact factor: 2.209

Review 4.  Review of cystic and solid tumors of the iris.

Authors:  Carol L Shields; Patrick W Shields; Janet Manalac; Chaisiri Jumroendararasame; Jerry A Shields
Journal:  Oman J Ophthalmol       Date:  2013-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.